TY  - JOUR
AU  - Guerra, Ivan
AU  - Perez-Jeldres, Tamara
AU  - Iborra, Marisa
AU  - Algaba, Alicia
AU  - Monfort, David
AU  - Calvet, Xavier
AU  - Chaparro, Maria
AU  - Mañosa, Miriam
AU  - Hinojosa, Esther
AU  - Minguez, Miguel
AU  - Ortiz de Zarate, Jone
AU  - Marquez, Lucia
AU  - Prieto, Vanessa
AU  - Garcia-Sanchez, Valle
AU  - Guardiola, Jordi
AU  - Rodriguez, G Esther
AU  - Martin-Arranz, Maria Dolores
AU  - Garcia-Tercero, Ivan
AU  - Sicilia, Beatriz
AU  - Masedo, Angeles
AU  - Lorente, Rufo
AU  - Rivero, Montserrat
AU  - Fernandez-Salazar, Luis
AU  - Gutierrez, Ana
AU  - Van Domselaar, Manuel
AU  - Lopez-SanRoman, Antonio
AU  - Ber, Yolanda
AU  - García-Sepulcre, Marife
AU  - Ramos, Laura
AU  - Bermejo, Fernando
AU  - Gisbert, Javier P
PY  - 2016
DO  - 10.1097/MIB.0000000000000757
UR  - http://hdl.handle.net/10668/9886
T2  - Inflammatory bowel diseases
AB  - Psoriasis induced by anti-tumor necrosis factor-α (TNF) therapy has been described as a paradoxical side effect. To determine the incidence, clinical characteristics, and management of psoriasis induced by anti-TNF therapy in a large nationwide cohort...
LA  - en
PB  - Oxford University Press
KW  - Adalimumab
KW  - Anti-TNF
KW  - Crohn’s disease
KW  - Inflammatory bowel disease
KW  - Infliximab
KW  - Psoriasis
KW  - Side effects
KW  - Ulcerative colitis
KW  - Adalimumab
KW  - Adolescent
KW  - Adult
KW  - Anti-inflammatory agents
KW  - Case-control studies
KW  - Cohort studies
KW  - Colitis, ulcerative
KW  - Crohn disease
KW  - Female
KW  - Follow-up studies
KW  - Gastrointestinal agents
KW  - Humans
KW  - Incidence
KW  - Infliximab
KW  - Male
KW  - Prognosis
KW  - Psoriasis
KW  - Spain
KW  - Tumor necrosis factor-alpha
KW  - Withholding treatment
TI  - Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
TY  - Research article
VL  - 22
ER  -